Goldman Sachs Group Inc Gracell Biotechnologies Inc. Transaction History

Goldman Sachs Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$2.43 - $10.04 $5,180 - $21,405	2,132 Added 13.34%	18,112 $181,000
Q3 2023 May 14, 2024	SELL	$2.83 - $4.9 $6,033 - $10,446	-2,132 Reduced 11.77%	15,980 $46,000
Q3 2023 Nov 14, 2023	SELL	$2.83 - $4.9 $3,605 - $6,242	-1,274 Reduced 7.38%	15,980 $46,000
Q2 2023 May 14, 2024	SELL	$1.45 - $6.07 $311 - $1,305	-215 Reduced 1.23%	17,254 $65,000
Q2 2023 Aug 14, 2023	SELL	$1.45 - $6.07 $311 - $1,305	-215 Reduced 1.23%	17,254 $65,000
Q1 2023 May 14, 2024	SELL	$1.8 - $2.5 $5,385 - $7,480	-2,992 Reduced 14.62%	17,469 $32,000
Q1 2023 May 11, 2023	SELL	$1.8 - $2.5 $5,385 - $7,480	-2,992 Reduced 14.62%	17,469 $32,000
Q4 2022 May 14, 2024	SELL	$2.08 - $3.96 $5,944 - $11,317	-2,858 Reduced 12.26%	20,461 $47,000
Q4 2022 Feb 13, 2023	SELL	$2.08 - $3.96 $5,944 - $11,317	-2,858 Reduced 12.26%	20,461 $47,000
Q3 2022 May 14, 2024	SELL	$2.08 - $5.15 $1,994 - $4,938	-959 Reduced 3.95%	23,319 $75,000
Q3 2022 Nov 10, 2022	SELL	$2.08 - $5.15 $1,994 - $4,938	-959 Reduced 3.95%	23,319 $75,000
Q2 2022 May 14, 2024	BUY	$1.95 - $5.5 $12,023 - $33,913	6,166 Added 34.04%	24,278 $134,000
Q2 2022 Aug 15, 2022	SELL	$1.95 - $5.5 $156,274 - $440,775	-80,141 Reduced 76.75%	24,278 $134,000
Q1 2022 May 16, 2022	BUY	$1.83 - $5.52 $158,295 - $477,479	86,500 Added 482.73%	104,419 $243,000
Q4 2021 Feb 14, 2022	BUY	$5.65 - $14.9 $101,242 - $266,993	17,919 New	17,919 $108,000

75.1K

Ticker GRCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,674,096
Description
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.